Judicial Scrutiny Over Healthcare Costs & Constitutional Rhetoric
Last updated:
Today's legal brief highlights critical judicial intervention against exorbitant pharmaceutical pricing along with major developments in constitutional proceedings. Additionally, state high courts continue to address instances of wrongful prosecution stemming from pandemic-era regulatory enforcement.
Supreme Court Condemns Exorbitant Cancer Drug Pricing and Patient Exploitation
The Supreme Court of India raised severe concerns regarding massive profit margins in vital healthcare services, noting instances where life-saving cancer drugs priced at a fraction of retailer cost were resold at exorbitant rates. The court emphasized the need for urgent regulatory intervention to curb predatory pricing practices and protect vulnerable patients from financial extortion.
Read Full StoryUnlock 2 more stories
Upgrade to Lawlit Pro to read the full daily brief, along with access to premium internships and the entire library.
Upgrade to ProGet Tomorrow’s Legal Brief on WhatsApp
Join 5,000+ law students. Wake up to curated legal briefs, landmark judgments, and top internships every morning at 9:00 AM. Zero spam.